Prof. Dr. Hasan KARANLIK

Yayın Ağı

Makaleler 86

1. Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a

Soran A., Göktepe B., Demirors B., Aytac O., Ozbas S., Dogan L., et al.

Current Oncology , cilt.32, sa.10, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Biologically Informed Decision-Making for PMRT in pT3N0M0 Luminal Breast Cancers (Protocol MF22-02): International Multicenter Real-World Data

Soran A., Gultekin M. B., Venkatesulu B. P., Barry P. N., King C., Bhargava R., et al.

Clinical Breast Cancer , cilt.25, sa.7, 2025 (SCI-Expanded)

3. Accuracy of Intraoperative Sentinel Lymph Node Evaluation by Imprint Cytology in Breast Cancer: A 12-Year Single Center Experience With 2,528 Patients

Bayram A., BAGBUDAR S., KARAOĞLAN Ç., Sayar E., Mollavelioğlu B., Tükenmez M., et al.

European Journal of Breast Health , cilt.21, sa.4, ss.333-338, 2025 (ESCI, Scopus, TRDizin)

4. Profile of surgical complications and complication-led reoperation rates in breast cancer patients who underwent oncoplastic breast surgery with volume displacements

Gulcelik M. A., Dogan L., KARANLIK H., Akinci M., UĞURLU M. Ü., Gulluoglu B. M.

European Journal of Surgical Oncology , cilt.51, sa.8, 2025 (SCI-Expanded)

5. Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study

Cabıoğlu N., KARANLIK H., Özmen V., Tükenmez M., İğci A., Aytin Y. E., et al.

Clinical Breast Cancer , cilt.25, sa.5, ss.455-463, 2025 (SCI-Expanded, Scopus)

6. Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study

Cabıoğlu N., KARANLIK H., İğci A., URAS C., DÜLGEROĞLU O., Karadeniz Çakmak G., et al.

European Journal of Surgical Oncology , cilt.51, sa.6, 2025 (SCI-Expanded, Scopus)

7. Is It Possible to Accurately Evaluate the Tumor Bed After Neoadjuvant Chemotherapy Using a 14G Tru-Cut Biopsy?

KILIÇ B., BADEMLER S., İLHAN M. B., KIZILDAĞ YIRGIN İ., Yilmaz R. S., Bayram A., et al.

Life (Basel, Switzerland) , cilt.15, sa.4, 2025 (SCI-Expanded)

8. Aselüler dermal matriks kullanılmadan gerçekleştirilen direkt implant ile tek aşamalı anında meme rekonstrüksiyonunun uzun dönem onkolojik güvenirliliği

kılıç b., Ilhan B., Karanlik H.

Turkish Journal of Clinics and Laboratory , cilt.16, sa.1, ss.76-85, 2025 (Hakemli Dergi)

9. De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer

CABIOĞLU N., Kocer H. B., KARANLIK H., Guelcelik M. A., Igci A., Muesluemanoglu M., et al.

JAMA SURGERY , cilt.160, sa.3, ss.257-266, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Totally implantable venous access devices: A fifteen-year single-center experience

kılıç b., Ilhan B., Karanlik H.

The European Research Journal , cilt.11, sa.2, ss.260-269, 2025 (Hakemli Dergi)

11. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i1): The OPBC-05/ICARO Study

Montagna G., Laws A., Ferrucci M., Mrdutt M. M., Sun S. X., BADEMLER S., et al.

Journal of Clinical Oncology , cilt.43, sa.7, ss.810-820, 2025 (SCI-Expanded, Scopus)

12. ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03

CABIOĞLU N., KARANLIK H., Igci A., Muslumanoglu M., Gulcelik M. A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

13. Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03

Cabioglu N., Karanlık H., Igci A., Muslumanoglu M., Gulcelik M. A., Uras C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.32, sa.2, ss.952-966, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is Administered

Cabioglu N., KARANLIK H., Igci A., Muslumanoglu M., Gulcelik M. A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.32, sa.2, ss.971-972, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Estrogen receptor positivity in stromal cells of the tumor bed predicts the response to neoadjuvant chemotherapy for breast carcinoma

BAYRAM A., Bagbudar S., KARANLIK H., CABIOĞLU N., AYDINER A., ÖNDER S., et al.

BREAST CANCER RESEARCH AND TREATMENT , 2025 (SCI-Expanded)

16. Role of Sentinel Lymph Node Biopsy with Blue Dye Only after Neoadjuvant Systemic Treatment in Patients with Breast Cancer Who Had Biopsy-Proven Node-Positive Disease at Admission: SENATURK-ROSANNA Study

Aktas A., Gurleyik M. G., Karadeniz Cakmak G., KARANLIK H., Ozkan Gurdal S., UĞURLU M. Ü., et al.

Breast Care , ss.1-9, 2025 (SCI-Expanded, Scopus)

17. Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy

Cabıoğlu N., KARANLIK H., Yılmaz R. S., Emiroğlu S., Tükenmez M., BADEMLER S., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.22, sa.1, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy

Montagna G., Mrdutt M. M., Sun S. X., Hlavin C., Diego E. J., Wong S. M., et al.

JAMA Oncology , cilt.10, sa.6, ss.793-798, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

19. FDG-guided excision of peripheral non-palpable lymph nodes in the axilla with suspected malignancy Excision guidée par FDG des ganglions lymphatiques non palpables de l'aisselle avec suspicion de malignité

İLHAN M. B., Kut A., BADEMLER S., KILIÇ B., Yanar F., KARANLIK H.

Medecine Nucleaire , cilt.48, sa.1, ss.1-7, 2024 (SCI-Expanded)

20. The Effect of Adjuvant Therapies for Recurrence in Stage I Breast Cancer Patients: A Single Centre Experience

Doğan İ., Khanmammadov N., Aydin E., PAKSOY N., Ferhatoğlu F., AK N., et al.

Turk Onkoloji Dergisi , cilt.39, sa.3, ss.257-264, 2024 (ESCI, Scopus, TRDizin)

21. Evaluation of immune density, PD-L1, and CXCR4 expressions in metaplastic breast carcinoma to predict potential immunotherapy benefit.

Bagbudar S., KARANLIK H., Cabioglu N., Bayram A., Tükenmez M., AYDINER A., et al.

Medical oncology (Northwood, London, England) , cilt.41, sa.1, ss.18, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

22. Conventional Tools for Predicting Satisfactory Response to Neoadjuvant Chemotherapy in HR+/HER2-Breast Cancer Patients

Oprea A. L., GÜLLÜOĞLU M. B., Aytin Y. E., EREN Ö. C., Aral C., Szekely T., et al.

BREAST CARE , cilt.18, ss.344-353, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

23. Pushing the Limits of Breast Conserving Surgery with Extreme Oncoplasty

Kilic B., BADEMLER S., İLHAN M. B., Yildirim I., Kucucuk S., Bayram A., et al.

BREAST CARE , 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

24. The impact of intraoperative cavity shaving on re-excision rates in breast-conserving surgery

Ilhan B., Bademler S., Kilic B., Onder S., KARANLIK H.

JOURNAL OF SURGICAL ONCOLOGY , cilt.127, sa.4, ss.527-534, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Investigation of mRNA Expression Levels of Tip60 and Related DNA Repair Genes in Molecular Subtypes of Breast Cancer

Salihoğlu E., Demokan S., Karanlık H., Karahalil B., Önder S., Cömert S., et al.

Clinical Breast Cancer , cilt.23, sa.2, ss.125-134, 2023 (SCI-Expanded)

26. Risk Factor Mapping Associated with Breast Cancer: A National-Based Study

ILHAN B., bademler s., DİŞÇİ R., KARANLIK H.

Comprehensive medicine , cilt.15, sa.1, ss.27-34, 2023 (Hakemli Dergi)

27. Pure Mucinous Breast Carcinoma With a Favorable Tumor Biology and Clinical Outcomes

EMİROĞLU S., Tukenmez M., Karakus S., KARANLIK H., Onder S., Ozmen V., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.18, sa.4, ss.353-359, 2022 (ESCI)

28. Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy

Weber W. P., Shaw J., Pusic A., Wyld L., Morrow M., King T., et al.

BREAST , cilt.63, ss.123-139, 2022 (SCI-Expanded)

29. Sentinel lymph node biopsy with/without axillary dissection in clinically node-positive breast cancer after neoadjuvant chemotherapy

Cabioglu N., Karanlik H., Gulcelik M. A., Ilgun S., Igci A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.69-70, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

30. Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?

Cabioglu N., Karanlik H., Igci A., Muslumanoglu M., Tukenmez M., Emiroglu S., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.310-311, 2022 (SCI-Expanded, Scopus)

31. Intervention to hepatic and pulmonary METastases in breast cancer patients: Prospective, multi-institutional registry study-IMET; Protocol MF 14-02

Soran A., Ozbas S., Ozcinar B., IŞIK A., Dogan L., ŞENOL K., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.30-31, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS , cilt.233, sa.6, ss.742-752, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

33. The relative importance of factors influencing the surgeons' choice between mastectomy and breast-conserving surgery for women with breast cancer

Hançerlioğulları Köksalmış G., Cetinguc B., Durucu M., Camgöz Akdağ H., Gulluoglud B. M., Karanlik H., et al.

HEALTH CARE FOR WOMEN INTERNATIONAL , 2021 (SSCI) Sürdürülebilir Kalkınma

34. Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment

Karanlik H., CABIOĞLU N., Oprea A. L., ÖZGÜR İ., AK N., AYDINER A., et al.

BREAST CARE , cilt.16, sa.5, ss.468-474, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

35. The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study

Soran A., Dogan L., Isik A., Ozbas S., Trabulus D. C., Demirci U., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.9, ss.5048-5057, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

36. The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q

Soran A., Soyder A., Ozbas S., Ozmen V., Karanlik H., Igci A., et al.

SUPPORTIVE CARE IN CANCER , cilt.29, sa.7, ss.3823-3830, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

37. Is There Any Advantage of Targeted Axillary Dissection After Neoadjuvant Chemotherapy in Patients with Initially Positive Clipped Node?

Cabioglu N., Karanlik H., Yilmaz R., Emiroglu S., Dursun M., Tukenmez M., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.SUPPL 2, 2021 (SCI-Expanded)

38. A Novel First-Line Treatment Alternative for Noncomplicated Idiopathic Granulomatous Mastitis: Combined Intralesional Steroid Injection with Topical Steroid Administration

Toktaş O., Konca C., Trabulus D. C., SOYDER A., Koksal H., Karanlik H., et al.

BREAST CARE , cilt.16, sa.2, ss.181-187, 2021 (SCI-Expanded)

39. Sentinel lymph node biopsy alone in locally advanced breast cancer after neoadjuvant chemotherapy: Turkish multicentric neosenti-turk MF-18-02-study

Cabioglu N., Karanlik H., Muslumanoglu M., Cakmak G. K., Trablus D. C., Tukenmez M., et al.

CANCER RESEARCH , cilt.81, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Assessment of death risk of breast cancer patients with joint frailty models

Pasin O., DİRİCAN A., ANKARALI H., Disci R., Karanlik H.

SAUDI MEDICAL JOURNAL , cilt.41, sa.5, ss.491-498, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

41. Surgical Trends in Breast Cancer in Turkey: An Increase in Breast-Conserving Surgery

Cakmak G. K., Emiroglu S., Sezer A., Cantürk N. Z., Yeniay L., Kuru B., et al.

JCO GLOBAL ONCOLOGY , cilt.6, ss.285-292, 2020 (ESCI) Sürdürülebilir Kalkınma

42. Correlation Between Gamma-Glutamyl Transferase Activity and Glutathione Levels in Molecular Subgroups of Breast Cancer

Akaydın S., Salihoğlu E., Gungor D. G., Karanlik H., Demokan S.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.16, sa.1, ss.72-76, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

43. Intraoperative palpation of sentinel lymph nodes can accurately predict axilla in early breast cancer

Ozkurt E., Yardımcı E., Tukenmez M., Ersoy Y. E., Yilmaz R. S., Cabioglu N., et al.

BREAST JOURNAL , cilt.25, ss.96-102, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

44. Port Kateter Uygulamaları: Kanserli Hastaların Deneyimlerine İlişkin Niteliksel Bir Çalışma

USLU Y., OLGUN N., KARANLIK H., USER İ.

Acıbadem Sağlık Bilimleri Dergisi , cilt.10, sa.3, ss.464-472, 2019 (Hakemli Dergi)

45. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.

Cabıoğlu N., Karanlık H., Kangal D., Ozkurt E., Öner G., Sezen F., et al.

Annals of surgical oncology , cilt.25, ss.3030-3036, 2018 (SCI-Expanded)

46. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.25, ss.3141-3149, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

47. Does the real-time ultrasound guidance provide safer venipuncture in implantable venous port implantation?

Yıldırım İ., Tütüncü A., Bademler S., Özgür İ., Demıray M., Karanlık H.

The journal of vascular access , cilt.19, ss.297-302, 2018 (SCI-Expanded)

48. Granulomatous lobular mastitis in pregnancy: a case report

Ilhan B., Kilic B., Bademler S., Ozgur I., Turkay R., Karanlik H.

CHIRURGIA-ITALY , cilt.30, sa.1, ss.33-35, 2017 (ESCI) Sürdürülebilir Kalkınma

49. Breast-Conserving Surgery Under Local Anesthesia in Elderly Patients with Severe Cardiorespiratory Comorbidities: A Hospital-Based Case-Control Study

Karanlik H., Kilic B., Yildirim I., Bademler S., Ozgur I., Ilhan B., et al.

BREAST CARE , cilt.12, sa.1, ss.29-33, 2017 (SCI-Expanded, Scopus)

50. Sentinel lymph node biopsy and aberrant lymphatic drainage in recurrent breast cancer: Findings likely to change treatment decisions

Karanlik H., Ozgur I., Kilic B., Fathalizadeh A., Sanli Y., Onder S., et al.

JOURNAL OF SURGICAL ONCOLOGY , cilt.114, sa.7, ss.796-802, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

51. Effect of intraperitoneal cetuximab administration on colonic anastomosis and early postoperative adhesion formation in a rat model

Kurt A., Karanlik H., Soylu S., Ozgur I., Soydinc H. O., Duranyildiz D., et al.

TURKISH JOURNAL OF SURGERY , cilt.32, sa.3, ss.157-161, 2016 (ESCI)

52. Factors affecting progression-free survival in non-HIV-related Kaposi sarcoma

Sen F., Tambas M., Ciftci R., Toz B., Kilic L., Bozbey H. U., et al.

JOURNAL OF DERMATOLOGICAL TREATMENT , cilt.27, sa.3, ss.275-277, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

53. Is sentinel lymph node biopsy enough for axillary macrometastasis?

Fayda M., Tambas M., Karanlik H.

TURKISH JOURNAL OF SURGERY , cilt.31, sa.4, ss.253-255, 2015 (ESCI)

54. Is there any effect of first-day usage of a totally implantable venous access device on complications?

Karanlik H., Odabas H., Yildirim I., Ozgur I., Kilic B., Sen F., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.20, sa.6, ss.1057-1062, 2015 (SCI-Expanded)

55. Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer Survival and Response to Treatment

Aydiner A., Sen F., Tambas M., Ciftci R., Eralp Y., Saip P., et al.

MEDICINE , cilt.94, sa.52, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

56. Intraoperative ultrasound reduces the need for re-excision in breast-conserving surgery

Karanlik H., Ozgur I., Sahin D., Fayda M., Onder S., Yavuz E.

WORLD JOURNAL OF SURGICAL ONCOLOGY , cilt.13, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

57. Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome

Karanlik H., Özgür I., Cabioglu N., Sen F., Erturk K., Kilic B., et al.

EJSO , cilt.41, sa.9, ss.1226-1233, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

58. Standardized Laparoscopic Sphincter-preserving Total Mesorectal Excision for Rectal Cancer: Long-term Oncologic Outcome in 217 Unselected Consecutive Patients

Asoglu O., Kunduz E., Serin K. R., Iscan Y., Karanlik H., Bakir B., et al.

SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES , cilt.24, sa.2, ss.145-152, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

59. Can Steroids plus Surgery Become a First-Line Treatment of Idiopathic Granulomatous Mastitis?

Karanlik H., Özgür I., Simsek S., Fathalizadeh A., Tukenmez M., Sahin D., et al.

BREAST CARE , cilt.9, sa.5, ss.338-342, 2014 (SCI-Expanded)

60. Effects of Intraperitoneal Bevacizumab Administration on Colonic Anastomosis and Early Postoperative Adhesion Formation

Karanlik H., KURT A., Kunduz E., Serin K. R., Saglam S., Soydinc H. O., et al.

SURGICAL INNOVATION , cilt.20, sa.6, ss.559-565, 2013 (SCI-Expanded)

61. Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer

Fayda M., Karanlik H.

LANCET ONCOLOGY , cilt.14, sa.7, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

62. TREATMENT APPROACHES FOR BREAST CANCER IN NETHERLAND CANCER INSTITUTE

KARANLIK H.

JOURNAL OF BREAST HEALTH , cilt.9, sa.2, ss.103-106, 2013 (ESCI)

63. Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients

Aydiner A., Kilic L., Yildiz I., Keskin S., Sen F., Kucucuk S., et al.

MEDICAL ONCOLOGY , cilt.30, sa.1, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Axillary Arch May Affect Axillary Lymphadenectomy

Karanlik H., Fathalizadeh A., Ilhan B., Serin K. R., Kurul S.

BREAST CARE , cilt.8, sa.6, ss.424-427, 2013 (SCI-Expanded)

65. Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation

KURT A., YANAR F., Asoglu O., Balik E., Olgac V., Karanlik H., et al.

BMC CLINICAL PATHOLOGY , cilt.12, 2012 (ESCI) Sürdürülebilir Kalkınma

66. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial

Karanlik H., Kurul S., Saip P., Unal E. S., Sen F., Disci R., et al.

AMERICAN JOURNAL OF SURGERY , cilt.202, sa.1, ss.10-15, 2011 (SCI-Expanded)

67. A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma

Saglam S., Aykan N. F., ŞAKAR B., GÜLLÜOĞLU M., Balik E., Karanlik H.

JOURNAL OF GASTROINTESTINAL ONCOLOGY , cilt.2, sa.1, ss.19-26, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

68. Extended latissimus dorsi myocutaneous flap for breast reconstruction: analysis of 30 patients

Kurul S., KARANLIK H., SAİP P. M., Kucucuk S., Aslay I.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.26, sa.4, ss.149-156, 2011 (ESCI)

69. Modification of Approach for Totally Implantable Venous Access Device Decreases Rate of Complications

Karanlik H., Kurul S.

JOURNAL OF SURGICAL ONCOLOGY , cilt.100, sa.3, ss.279-283, 2009 (SCI-Expanded)

70. Metastatic Lymph Node Ratio is an Independent Prognostic Factor in Gastric Cancer

Asoglu O., Karanlik H., Parlak M., Kecer M., Muslumanoglu M., Igci A., et al.

HEPATO-GASTROENTEROLOGY , cilt.56, ss.908-913, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

71. Impact of laparoscopic surgery on bladder and sexual function after total mesorectal excision for rectal cancer

Asoglu O., Matlim T., Karanlik H., Atar M., Muslumanoglu M., Kapran Y., et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES , cilt.23, ss.296-303, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

72. The Effect of Glyceryl Trinitrate Ointment on Posthemorrhoidectomy Pain and Wound Healing: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Karanlik H., Akturk R., Camlica H., Asoglu O.

DISEASES OF THE COLON & RECTUM , cilt.52, sa.2, ss.280-285, 2009 (SCI-Expanded)

73. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: A single institute experience

Asoglu O., KARANLIK H., Muslumanoglu M., Igci A., Emek E., Ozmen V., et al.

EJSO , cilt.33, sa.10, ss.1199-1206, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

74. Primary ovarian cancer presenting with axillary lymph node metastases: A report of two cases

Ozmen V., Asoglu O., Karanlık H., Cabıoglu N., Kecer M., Bakkaloglu H.

ACTA CHIRURGICA BELGICA , cilt.107, ss.75-77, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

75. LONG TERM RESULTS OF SURGICAL TREATMENT FOR BREAST CANCER

KARANLIK H., ÖZMEN V., Asoglu O., Igci A., Kecer M., Tuzlali S., et al.

JOURNAL OF BREAST HEALTH , cilt.2, sa.2, ss.89-95, 2006 (ESCI) Sürdürülebilir Kalkınma

76. Malignant phyllode tumor metastatic to the duodenum

Asoglu O., Karanlik H., Barbaros U., Yanar H., Kapran Y., Kecer M., et al.

WORLD JOURNAL OF GASTROENTEROLOGY , cilt.12, sa.10, ss.1649-1651, 2006 (SCI-Expanded)

77. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer

Ozmen V., KARANLIK H., CABIOGLU N., IGCI A., KECER M., ASOGLU O., et al.

BREAST CANCER RESEARCH AND TREATMENT , cilt.95, sa.1, ss.1-6, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

78. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy

ASOGLU O., Ozmen V., KARANLIK H., KECER M., MUZLUMZNOGLU M., IGCI A., et al.

ACTA CHIRURGICA BELGICA , cilt.105, sa.3, ss.291-296, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

79. Feasibility of surgical management in patients with granulomatous mastitis

Asoglu O., Ozmen V., Karanlık H., Tunacı M., Cabıoglu N., Igcı A., et al.

BREAST JOURNAL , cilt.11, ss.108-114, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

80. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer

ASOGLU O., MUSLUMANOGLU M. E., IGCI A., Ozmen V., KARANLIK H., AYALP K., et al.

ACTA CHIRURGICA BELGICA , cilt.105, sa.1, ss.62-68, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

81. IS A COMPLETION AXILLARY DISSECTION NECESSARY FOR PATIENTS WITH METATASIS IN SENTINEL LYMPH NODE?

ÖZMEN V., KARANLIK H., Asoglu O., Igci A., Muslumanoglu M., Kecer M., et al.

JOURNAL OF BREAST HEALTH , cilt.1, sa.1, ss.12-17, 2005 (ESCI) Sürdürülebilir Kalkınma

82. A CASE OF COEXISTENT ADENOCARCINOMA OF THE STOMACH AND T-CELL LYMPHOMA OF THE STOMACH AND JEJUNUM

Asoglu O., KARANLIK H., Korkut C., Bozfakioglu Y., Kapran Y., Agan M.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.68, sa.1, ss.22-25, 2005 (ESCI)

83. Does the early ligation of the splenic artery reduce hemorrhage during laparoscopic splenectomy?

ASOGLU O., Ozmen V., GORGUN E., KARANLIK H., KECER M., IGCI A., et al.

SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES , cilt.14, sa.3, ss.118-121, 2004 (SCI-Expanded)

84. Does the complication rate increase in laparoscopic cholecystectomy for acute cholecystitis?

ASOGLU O., Ozmen V., KARANLIK H., IGCI A., KECER M., PARLAK M., et al.

JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES-PART A , cilt.14, sa.2, ss.81-86, 2004 (SCI-Expanded)

85. Laparoscopic treatment of mesenteric cysts

ASOGLU O., IGCI A., KARANLIK H., PARLAK M., KECER M., Ozmen V., et al.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES , cilt.17, sa.5, 2003 (SCI-Expanded)

86. Bilateral nipple necrosis in a breastfeeding woman with Behcet's disease

Uludag M., Yetkin G., Kebudi A., Isgor A., Basak T., KARANLIK H., et al.

BREAST , cilt.11, sa.6, ss.522-525, 2002 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 36

1. PATIENT REPORTED OUTCOMES AND LYMPHEDEMA IN NODE-POSITIVE BREAST CANCER IN THE EARLY POSTOPERATIVE PERIOD AFTER NEOADJUVANT CHEMOTHERAPY IN THE PROSPECTIVE NEOSENTITURK-trial MF18-03

CABIOĞLU N., GÜL KILIÇ H., Bozdoğan A., Rumisa Kılıç B., USLU Y., EMİROĞLU S., et al.

San Antonio Breast Cancer Symposium, New York, Amerika Birleşik Devletleri, 10 Aralık 2024, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

2. Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study

Cabioglu N., KARANLIK H., Gulcelik M. A., Kocer H. B., Muslumanoglu M., Igci A., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, (Özet Bildiri)

3. Imaging tailored axillary approach combined with radiotherapy eliminates axillary lymph node dissection in low-volume axillary disease after neoadjuvant chemotherapy

Muslumanoglu M., MOLLAVELİOĞLU B., EMİROĞLU S., KARANLIK H., Tukenmez M., İBİŞ K., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, cilt.84, (Özet Bildiri)

4. PMRT Decision with low prediction of genomic test score in pT3N0M0 luminal breast cancer: Protocol MF22-02: International multicenter realworld data

Soran A., King C., Barry P. N., Bhargava R., KARANLIK H., Gultekin M., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, (Özet Bildiri)

5. Combined Analysis of the MF18-02/03 Neosentiturk Studies: Factors Predicting Recurrence in ycN0/ypN-positive Breast Cancer with Sentinel Lymph Node Biopsy - Or Targeted Axillary Dissection - Alone After Neoadjuvant Chemotherapy

Cabioglu N., Muslumanoglu M., Igci A., KARANLIK H., TÜKENMEZ M., Gulcelik M. A., et al.

24th Annual Meeting of The American Society of Breast Surgeons (ASBrS), Mississippi, Amerika Birleşik Devletleri, 26 - 30 Nisan 2023, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Locoregional Treatment Improves Survival in De Novo Bone-only Metastatic Breast Cancer: Long-term Results of the Prospective, Multi-institutional Study - Protocol BOMET MF14-01

Soran A., Dogan L., Isik A., Ozbas S., Can-Trabulus D., Demirci U., et al.

24th Annual Meeting of The American Society of Breast Surgeons (ASBrS), Mississippi, Amerika Birleşik Devletleri, 26 - 30 Nisan 2023, (Özet Bildiri) Sürdürülebilir Kalkınma

7. AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03

Cabioglu N., KARANLIK H., Gulcelik M. A., Igci A., Muslumanoglu M., Kocer H. B., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 6 - 10 Aralık 2022, (Özet Bildiri)

8. Factors predicting a lower likelihood of residual nodal disease in clinically-node positive patients undergoing sentinel node surgery after neoadjuvant chemotherapy for breast cancer

Cabioglu N., KARANLIK H., Igci A., Muslumanoglu M., TÜKENMEZ M., EMİROĞLU S., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 7 - 10 Aralık 2021, (Özet Bildiri)

9. Favorable local control in breast cancer patients following sentinel lymph node biopsy after neoadjuvant chemotherapy without axillary lymph node dissection

Cabioglu N., Igci A., Karanlik H., Muslumanoglu M., Cakmak G. K., Emirikci S., et al.

20th Annual Meeting of the American-Society-of-Breast-Surgeons, Texas, Amerika Birleşik Devletleri, 30 Nisan - 05 Mayıs 2019, cilt.26, ss.292-293, (Özet Bildiri) Sürdürülebilir Kalkınma

10. Tensin-2 Molekülünün Meme Kanserli Hastalardaki Önemi

TİLGEN YASASEVER C., BİLGİN E., serilmez m., OĞUZ SOYDİNÇ H., BADEMLER S., KARANLIK H.

29. Ulusal Biyokimya Kongresi Bodrum-Muğla, Muğla, Türkiye, 26 - 30 Ekim 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

11. A randomized controlled trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer: Turkish Study (Protocol MF07-01).

Soran A., Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34, (Özet Bildiri) Sürdürülebilir Kalkınma

12. Port Catheter Applications: A Qualitative Study on Experience of Cancer Patients

USLU Y., OLGUN N., KARANLIK H., USER İ.

19th International Nursing Research Conference, Madrid, İspanya, 17 - 20 Kasım 2015, (Özet Bildiri)

13. Factors affecting progression free survival in non-HIV related classical Kaposi sarcoma.

Sen F., Tambas M., Ciftci R., Toz B., Kilic L., Bozbey H. U., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Clinical distuingishing characteristics and management of phyllodes tumors of the breast.

Tukenmez M., Kulle C. B., Velidedeoglu M., Agcaoglu O., Parlakgul G., Aydogan F., et al.

15. Effectiveness of Pilates-based exercises on upper extremity disorders related with breast cancer treatment.

ZENGİN ALPÖZGEN A., Neriman Narin A., ÖZDİNÇLER A., KARANLIK H., AĞAOĞLU F.

13th Congress of Europen Forum for Research in Rehabilitation., Helsinki, Finlandiya, 6 - 09 Mayıs 2015, ss.30, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

16. Pure Mucinous Carcinoma With a Favorable Tumor Biology and Prognosis

Karakus S., Tukenmez M., Ucuncu M., Yuksel S., Karanlik H., Yavuz E., et al.

16th Annual Meeting of the American-Society-of-Breast-Surgeons, Florida, Amerika Birleşik Devletleri, 29 Nisan - 03 Mayıs 2015, cilt.22, ss.65, (Özet Bildiri)

17. Neoadjuvan kemoterapi uygulanan meme kanserli hastalarda PET BT ile tedavi yanıtının değerlendirilmesi

GEÇER M. F., MUDUN A., ŞANLI Y., KUYUMCU S., YILMAZ E., ÖZKAN Z. G., et al.

27. Ulusal Nükleer Tıp Kongresi, Türkiye, 1 - 05 Nisan 2015, cilt.1, ss.7

18. Distribution and frequency of BRCA gene mutations in Turkish population including Balkan Turks

AKDENIZ D., Tuncer B. S., kılıç S., şükrüoğlu O., Kilic L., ALTUNDAĞ K., et al.

AACR Special Conference on Cancer Susceptibility and Cancer Susceptibility Syndromes, California, Amerika Birleşik Devletleri, 29 Ocak - 01 Şubat 2014, cilt.74, (Özet Bildiri)

19. Association of NBS1 expression with improved pathologic complete response rate in HER2-overexpressing breast cancer.

Sen F., Yavuz E., Yegen G., Karanlik H., Tuzlali S., Aydiner A.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri) Sürdürülebilir Kalkınma

20. Türk Toplumundaki Meme Kanserli Hastalarda BRCA Mutasyon Dağılımlarının Klinik Faktörlerle İlişkisi

kılıç l., ŞEN F., Yıldız i., keskin s., KARANLIK H., EKENEL M., et al.

20.Ulusal Kanser Kongresi, Antalya, Türkiye, 20 - 23 Nisan 2013, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

21. Standardized laparoscopic sphincter-preserving total mesorectal excision for rectal cancer: long-term oncologic outcome in 217 unselected patients

Asoğlu O., Kunduz E., Serin K. R., İşcan A. Y., Karanlık H., Bakır B., et al.

16. Annual Meeting of the European Society of Surgery, İstanbul, Türkiye, 22 - 24 Kasım 2012, cilt.44, ss.6, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

22. İleri Evre Klasik Kaposi Sarkomlu Hastaların Birinci Seçim Tedavisinde Oral Etoposit

ŞEN F., Yıldız i., kılıç l., keskin s., KARANLIK H., TUNÇER Ş. B., et al.

4. Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 21 - 22 Mart 2012, ss.284, (Özet Bildiri)

23. HIV-Negatif Kaposi Sarkomunda Penis ve Skrotum Tutulumu

ŞEN F., Yıldız İ., KARANLIK H., TOZ B., TUNÇER Ş. B., Ünal E., et al.

19.Ulusal Kanser Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2011, ss.618, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

24. HIV-Negatif Kaposi Sarkomlu Hastalarda Serum Human Herpes Virus 8 DNA Pozitiflik Oranı

ŞEN F., TUNÇER Ş. B., YAZICI H., KURUL S., KARANLIK H., AYDINER A.

19.Ulusal Kanser Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2011, ss.311, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

25. Meme Kanserli Hastalara Ait PrimerTümör Dokusundaki Metilasyon Değişikliklerinin 2 ve 3 Boyutlu Doku Kültür Ortamında Araştırılması

ŞÜKRÜOĞLU ERDOĞAN Ö., YAZICI H., DALAY M. N., BİLİR A., KURUL S., KARANLIK H.

19. Ulusal Kanser Kongresi, Antalya, Türkiye, 20 - 24 Nisan 2011, ss.485, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

26. K-RAS mutasyonları ve bevasizumab etkinliği arasında ilişki var mıdır?

KILIÇ L., EKENEL M., YALNIZ Z., ŞEN F., YILDIZ İ., KARANLIK H., et al.

19. Ulusal Kanser Kongresi, Antalya, Türkiye, 20 - 24 Nisan 2011, ss.234, (Tam Metin Bildiri)

27. Orta ve distal yerleşimli rektum kanserlerinin tedavisinde laparoskopik yöntem sfinkter koruyucu cerrahi yapılabilirliğini arttırıyor mu?

İlhan M. B., Kunduz E., İşcan A. Y., Karanlık H., Balık E., Asoğlu O., et al.

17. Ulusal Cerrahi Kongresi, Ankara, Türkiye, 26 - 29 Mayıs 2010, ss.60, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

28. Laparoskopik kolon kanseri cerrahisinde açık cerrahiye dönüşün onkolojij sonuçlar üzerine etkisi

İşcan A. Y., İlhan M. B., Kunduz E., Karanlık H., Balık E., Asoğlu O., et al.

17. Ulusal Cerrahi Kongresi, Ankara, Türkiye, 26 - 29 Mayıs 2010, ss.131, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

29. Laparoskopik tedavi edilen rektum kanseri olgularında neoadjuvan radyoterapinin cerrahiye etkileri

Balık E., Kunduz E., Karanlık H., İlhan M. B., İşcan A. Y., Sökücü N., et al.

9. Ulusal Endoskopik Laparoskopik Cerrahi Kongresi, Antalya, Türkiye, 28 - 31 Ekim 2009, ss.106-107, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

30. MEME KANSER! HASTALARINDA cerbB-2 EKSPRESYONUNUN SAĞKALİMA ETKİSİ

İĞCİ A., KARANLIK H., SERİN K. R., PARLAK M., KEÇER M., MÜSLÜMANOĞLU M. E., et al.

ULUSAL CERRAHİ KONGRESİ 2006, Antalya, Türkiye, 24 - 28 Mayıs 2006, (Tam Metin Bildiri)

31. ÖZOFAGUS KANSERİ TAKİP SONUÇLARIMIZ

Asoğlu O., Özçınar B., Müslümanoğlu M. E., İğci A., Özmen V., Keçer M., et al.

3. ULUSAL CERRAHİ ONKOLOJİ KONGRESİ, Antalya, Türkiye, 9 - 12 Kasım 2005, ss.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

32. Meme Kanseri Hastalarında cerb 2 Ekspresyonunun sağkalıma Etkisi

İĞCİ A., KARANLIK H., SERİN K. R., PARLAK M., KEÇER M., MÜSLÜMANOĞLU M. E., et al.

VIII. Ulusal Meme Hastalıkları Kongresi, Türkiye, 21 - 24 Eylül 2005

33. SENTİNEL LENF NODÜLÜ BİYOPSİSİNDE MİKROMETASTAZ SAPTANAN MEME KANSERİ HASTALARINDA AKSİLLER DİSEKSİYON GEREKLİ MİDİR?

Özmen V., Karanlık H., Özçınar B., Müslümanoğlu M. E., İğci A., Keçer M., et al.

8. Ulusal Meme Hastalıkları Kongresi, İstanbul, Türkiye, 21 - 24 Eylül 2005, ss.200, (Özet Bildiri) Sürdürülebilir Kalkınma

Kitaplar 1

1. Güvenli Tedavinin Sağlanması “Ekstravazasyon”

ÖZBAŞ A., Genç A., Yüntem A., Bitirgen C., Karalar Ü., AKYÜZ N., et al.

Onkoloji Hemşireliğinde Kanıttan Uygulamaya - Konsensus 2014, Can G, Editör, Nobel Tıp Kitabevleri, İstanbul, ss.61-67, 2015

Metrikler

Yayın

123

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

1098

H-İndeks (WoS)

Atıf (Scopus)

1283

H-İndeks (Scopus)

Atıf (Scholar)

188

H-İndeks (Scholar)

Atıf (Sobiad)

H-İndeks (Sobiad)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (Sobiad)

H-İndeks (Sobiad)

Proje

Açık Erişim